Evidence map›Paper›PMID 25191568›Full record

ArticleJournal of nutritional science2013

A salmon peptide diet alleviates experimental colitis as compared with fish oil.

Tore Grimstad, Bodil Bjørndal, Daniel Cacabelos, Ole G Aasprong, Roald Omdal, Asbjørn Svardal, Pavol Bohov, Reinald Pamplona, Manuel Portero-Otin, Rolf K Berge and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of nutritional science, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Opening a Window on Attention: Adjuvant Therapies for Inflammatory Bowel Disease.Canadian journal of gastroenterology & hepatology · 2020
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Tore GrimstadDivision of Gastroenterology, Department of Medicine , Stavanger University Hospital , Stavanger , Norway ; Institute of Medicine, University of Bergen , Bergen , Norway.
Bodil BjørndalSection of Clinical Biochemistry, Haukeland University Hospital , Bergen , Norway.
Daniel CacabelosDepartment of Experimental Medicine , University of Lleida (IRB Lleida) , Lleida , Spain.
Ole G AasprongDepartment of Pathology , Stavanger University Hospital , Stavanger , Norway.
Roald OmdalInstitute of Medicine, University of Bergen , Bergen , Norway ; Department of Medicine , Stavanger University Hospital , Stavanger , Norway.
Asbjørn SvardalInstitute of Medicine, University of Bergen , Bergen , Norway.
Pavol BohovSection of Clinical Biochemistry, Haukeland University Hospital , Bergen , Norway.
Reinald PamplonaDepartment of Experimental Medicine , University of Lleida (IRB Lleida) , Lleida , Spain.
Manuel Portero-OtinDepartment of Experimental Medicine , University of Lleida (IRB Lleida) , Lleida , Spain.
Rolf K BergeSection of Clinical Biochemistry, Haukeland University Hospital , Bergen , Norway ; Department of Heart Diseases , Haukeland University Hospital , Bergen , Norway.
Trygve HauskenInstitute of Medicine, University of Bergen , Bergen , Norway ; Division of Gastroenterology, Department of Medicine , Haukeland University Hospital , Bergen , Norway.
University of Bergen · NOHaukeland University Hospital · NOUniversitat de Lleida · ESBiomedical Research Institute of Lleida · ESStavanger University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fish oil (FO) has been shown to have anti-inflammatory properties in animal models of inflammatory bowel disease, but how fish peptides (FP) influence intestinal inflammation has been less studied. Male Wistar rats, divided into five groups, were included in a 4-week dietary intervention study. Of the groups, four were exposed in the fourth week to 5 % dextran sulfate sodium (DSS) to induce colitis, while one group was unexposed. The diets were: (1) control, (2) control + DSS, (3) FO (5 %) + DSS, (4) FP (3·5 %) + DSS, (5) FO + FP + DSS. Following DSS intake, weight and disease activity index (DAI) were assessed, and histological combined score (HCS), selected colonic PG, cytokines, oxidative damage markers and mRNA levels were measured. FP reduced HCS, tended to lower DAI (P = 0·07) and reduced keratinocyte chemoattractant/growth-regulated oncogene levels, as compared with the FO diet. FP also reduced mRNA levels of Il-6 and Cxcl1, although not significantly. FO intake increased the DAI as compared with DSS alone. PGE3 levels increased after the FO diet, and even more following FO + FP intake. The FP diet seems to have a protective effect in DSS-induced colitis as compared with FO. A number of beneficial, but non-significant, changes also occurred after FP v. DSS. A combined FO + FP diet may influence PG synthesis, as PGE3 levels were higher after the combined diet than after FO alone.

Indexed as

ColitisDAI, disease activity indexDiet therapyDSS, dextran sulfate sodiumFO, fish oilFP, fish peptideGRO, growth-regulated oncogeneHCS, histological combined scoreIBD, inflammatory bowel diseaseInflammatory bowel diseasesKC, keratinocyte chemoattractantn-3 Fatty acidsUC, ulcerative colitis

Identifiers

PMID25191568
PMCPMC4153328
OpenAlexW2002864652

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.